Annual CFI:
-$553.10M-$792.35M(-331.18%)Summary
- As of today, CYTK annual cash from investing is -$553.10 million, with the most recent change of -$792.35 million (-331.18%) on December 31, 2024.
- During the last 3 years, CYTK annual cash from investing has fallen by -$405.32 million (-274.28%).
- CYTK annual cash from investing is now -331.18% below its all-time high of $239.25 million, reached on December 31, 2023.
Performance
CYTK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$52.88M-$53.08M(-50.09%)Summary
- As of today, CYTK quarterly cash from investing is $52.88 million, with the most recent change of -$53.08 million (-50.09%) on June 30, 2025.
- Over the past year, CYTK quarterly cash from investing has increased by +$704.43 million (+108.12%).
- CYTK quarterly cash from investing is now -68.05% below its all-time high of $165.50 million, reached on March 31, 2023.
Performance
CYTK Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$224.65M+$704.43M(+146.82%)Summary
- As of today, CYTK TTM cash from investing is $224.65 million, with the most recent change of +$704.43 million (+146.82%) on June 30, 2025.
- Over the past year, CYTK TTM cash from investing has increased by +$851.93 million (+135.81%).
- CYTK TTM cash from investing is now -35.80% below its all-time high of $349.91 million, reached on September 30, 2023.
Performance
CYTK TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CYTK Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -331.2% | +108.1% | +135.8% |
| 3Y3 Years | -274.3% | -19.0% | +240.1% |
| 5Y5 Years | -640.4% | +52.7% | +275.3% |
CYTK Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -331.2% | at low | -68.0% | +108.1% | -35.8% | +130.1% |
| 5Y | 5-Year | -331.2% | at low | -68.0% | +108.1% | -35.8% | +130.1% |
| All-Time | All-Time | -331.2% | at low | -68.0% | +108.1% | -35.8% | +130.1% |
CYTK Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $52.88M(-50.1%) | $224.65M(+146.8%) |
| Mar 2025 | - | $105.96M(-4.4%) | -$479.78M(+13.3%) |
| Dec 2024 | -$553.10M(-331.2%) | $110.86M(+346.1%) | -$553.10M(+25.8%) |
| Sep 2024 | - | -$45.05M(+93.1%) | -$745.37M(-18.8%) |
| Jun 2024 | - | -$651.55M(-2096.1%) | -$627.28M(-689.6%) |
| Mar 2024 | - | $32.64M(+140.1%) | $106.40M(-55.5%) |
| Dec 2023 | $239.25M(+191.3%) | -$81.41M(-211.5%) | $239.25M(-31.6%) |
| Sep 2023 | - | $73.04M(-11.1%) | $349.91M(+2357.8%) |
| Jun 2023 | - | $82.13M(-50.4%) | -$15.50M(+52.1%) |
| Mar 2023 | - | $165.50M(+465.8%) | -$32.36M(+87.7%) |
| Dec 2022 | -$262.13M(-77.4%) | $29.25M(+110.0%) | -$262.13M(-7.4%) |
| Sep 2022 | - | -$292.37M(-548.0%) | -$244.05M(-52.2%) |
| Jun 2022 | - | $65.27M(+201.5%) | -$160.39M(+22.4%) |
| Mar 2022 | - | -$64.28M(-235.8%) | -$206.78M(-39.9%) |
| Dec 2021 | -$147.78M(+24.8%) | $47.34M(+122.7%) | -$147.78M(+59.9%) |
| Sep 2021 | - | -$208.72M(-1205.4%) | -$368.73M(-41.3%) |
| Jun 2021 | - | $18.88M(+457.9%) | -$261.04M(-6.4%) |
| Mar 2021 | - | -$5.28M(+97.0%) | -$245.28M(-24.8%) |
| Dec 2020 | -$196.51M(-163.0%) | -$173.62M(-71.9%) | -$196.51M(-53.3%) |
| Sep 2020 | - | -$101.02M(-391.7%) | -$128.16M(-852.3%) |
| Jun 2020 | - | $34.64M(-20.4%) | -$13.46M(+73.5%) |
| Mar 2020 | - | $43.49M(+141.3%) | -$50.86M(+31.9%) |
| Dec 2019 | -$74.71M(-1555.4%) | -$105.27M(-869.4%) | -$74.71M(-230.9%) |
| Sep 2019 | - | $13.68M(+594.5%) | $57.07M(+23.9%) |
| Jun 2019 | - | -$2.77M(-114.1%) | $46.06M(+892.5%) |
| Mar 2019 | - | $19.64M(-25.9%) | $4.64M(-9.6%) |
| Dec 2018 | $5.13M(+107.8%) | $26.51M(+890.2%) | $5.13M(-45.3%) |
| Sep 2018 | - | $2.68M(+106.1%) | $9.39M(-79.8%) |
| Jun 2018 | - | -$44.19M(-319.4%) | $46.37M(-30.4%) |
| Mar 2018 | - | $20.14M(-34.5%) | $66.61M(+201.2%) |
| Dec 2017 | -$65.83M(-26.4%) | $30.76M(-22.4%) | -$65.83M(+52.5%) |
| Sep 2017 | - | $39.66M(+265.6%) | -$138.56M(+15.6%) |
| Jun 2017 | - | -$23.95M(+78.7%) | -$164.25M(-13.9%) |
| Mar 2017 | - | -$112.30M(-167.6%) | -$144.22M(-176.9%) |
| Dec 2016 | -$52.08M(-424.2%) | -$41.97M(-400.4%) | -$52.08M(-440.3%) |
| Sep 2016 | - | $13.97M(+456.8%) | $15.30M(+21.1%) |
| Jun 2016 | - | -$3.92M(+80.6%) | $12.64M(-54.8%) |
| Mar 2016 | - | -$20.16M(-179.3%) | $28.00M(+74.3%) |
| Dec 2015 | $16.06M(+496.7%) | $25.41M(+124.8%) | $16.06M(+627.7%) |
| Sep 2015 | - | $11.31M(-1.2%) | -$3.04M(+28.9%) |
| Jun 2015 | - | $11.44M(+135.6%) | -$4.28M(+41.2%) |
| Mar 2015 | - | -$32.09M(-609.1%) | -$7.28M(-79.8%) |
| Dec 2014 | -$4.05M | $6.30M(-37.4%) | -$4.05M(+10.8%) |
| Sep 2014 | - | $10.07M(+19.3%) | -$4.54M(+79.5%) |
| Jun 2014 | - | $8.44M(+129.2%) | -$22.20M(+45.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$28.86M(-596.5%) | -$40.85M(-2589.2%) |
| Dec 2013 | -$1.52M(+94.7%) | $5.81M(+176.6%) | -$1.52M(-112.2%) |
| Sep 2013 | - | -$7.59M(+25.6%) | -$716.00K(+97.8%) |
| Jun 2013 | - | -$10.21M(-197.5%) | -$32.10M(-37.2%) |
| Mar 2013 | - | $10.47M(+58.3%) | -$23.40M(+18.8%) |
| Dec 2012 | -$28.82M(-213.9%) | $6.62M(+117.0%) | -$28.82M(-8.2%) |
| Sep 2012 | - | -$38.97M(-2482.8%) | -$26.64M(-260.5%) |
| Jun 2012 | - | -$1.51M(-129.9%) | $16.60M(-13.9%) |
| Mar 2012 | - | $5.05M(-42.5%) | $19.28M(-23.8%) |
| Dec 2011 | $25.30M(-26.1%) | $8.79M(+106.2%) | $25.30M(+221.9%) |
| Sep 2011 | - | $4.26M(+263.9%) | $7.86M(-70.2%) |
| Jun 2011 | - | $1.17M(-89.4%) | $26.36M(-35.1%) |
| Mar 2011 | - | $11.07M(+228.0%) | $40.60M(+18.6%) |
| Dec 2010 | $34.24M(+164.0%) | -$8.65M(-138.0%) | $34.24M(-33.3%) |
| Sep 2010 | - | $22.76M(+47.6%) | $51.36M(+369.5%) |
| Jun 2010 | - | $15.42M(+227.8%) | -$19.05M(+60.7%) |
| Mar 2010 | - | $4.70M(-44.5%) | -$48.53M(+9.3%) |
| Dec 2009 | -$53.48M(-436.6%) | $8.47M(+117.8%) | -$53.48M(+30.5%) |
| Sep 2009 | - | -$47.65M(-239.0%) | -$77.00M(-175.0%) |
| Jun 2009 | - | -$14.05M(-5544.2%) | -$28.00M(-99.6%) |
| Mar 2009 | - | -$249.00K(+98.3%) | -$14.03M(-40.7%) |
| Dec 2008 | -$9.97M(-121.9%) | -$15.05M(-1210.0%) | -$9.97M(-138.4%) |
| Sep 2008 | - | $1.36M(+1733.7%) | $25.95M(+2.9%) |
| Jun 2008 | - | -$83.00K(-102.2%) | $25.21M(-45.6%) |
| Mar 2008 | - | $3.81M(-81.7%) | $46.34M(+1.9%) |
| Dec 2007 | $45.46M(+432.3%) | $20.87M(+3292.8%) | $45.46M(+701.0%) |
| Sep 2007 | - | $615.00K(-97.1%) | -$7.57M(-40.6%) |
| Jun 2007 | - | $21.05M(+618.2%) | -$5.38M(+88.0%) |
| Mar 2007 | - | $2.93M(+109.1%) | -$45.01M(-229.0%) |
| Dec 2006 | -$13.68M(-139.7%) | -$32.16M(-1248.6%) | -$13.68M(-156.1%) |
| Sep 2006 | - | $2.80M(+115.1%) | $24.40M(-21.2%) |
| Jun 2006 | - | -$18.58M(-154.2%) | $30.98M(-46.5%) |
| Mar 2006 | - | $34.26M(+478.5%) | $57.89M(+67.8%) |
| Dec 2005 | $34.49M(+152.7%) | $5.92M(-36.8%) | $34.49M(+6.6%) |
| Sep 2005 | - | $9.38M(+12.6%) | $32.36M(-5.5%) |
| Jun 2005 | - | $8.33M(-23.3%) | $34.24M(+157.2%) |
| Mar 2005 | - | $10.86M(+186.2%) | -$59.86M(+8.6%) |
| Dec 2004 | -$65.51M(-333.2%) | $3.79M(-66.3%) | -$65.51M(+5.5%) |
| Sep 2004 | - | $11.26M(+113.1%) | -$69.30M(+14.0%) |
| Jun 2004 | - | -$85.77M(-1744.1%) | -$80.56M(-1644.1%) |
| Mar 2004 | - | $5.22M | $5.22M |
| Dec 2003 | -$15.12M(-167.0%) | - | - |
| Dec 2002 | $22.58M(+196.0%) | - | - |
| Dec 2001 | -$23.53M(+6.4%) | - | - |
| Dec 2000 | -$25.12M | - | - |
FAQ
- What is Cytokinetics, Incorporated annual cash from investing?
- What is the all-time high annual cash from investing for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual cash from investing year-on-year change?
- What is Cytokinetics, Incorporated quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly cash from investing year-on-year change?
- What is Cytokinetics, Incorporated TTM cash from investing?
- What is the all-time high TTM cash from investing for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated TTM cash from investing year-on-year change?
What is Cytokinetics, Incorporated annual cash from investing?
The current annual cash from investing of CYTK is -$553.10M
What is the all-time high annual cash from investing for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual cash from investing is $239.25M
What is Cytokinetics, Incorporated annual cash from investing year-on-year change?
Over the past year, CYTK annual cash from investing has changed by -$792.35M (-331.18%)
What is Cytokinetics, Incorporated quarterly cash from investing?
The current quarterly cash from investing of CYTK is $52.88M
What is the all-time high quarterly cash from investing for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly cash from investing is $165.50M
What is Cytokinetics, Incorporated quarterly cash from investing year-on-year change?
Over the past year, CYTK quarterly cash from investing has changed by +$704.43M (+108.12%)
What is Cytokinetics, Incorporated TTM cash from investing?
The current TTM cash from investing of CYTK is $224.65M
What is the all-time high TTM cash from investing for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high TTM cash from investing is $349.91M
What is Cytokinetics, Incorporated TTM cash from investing year-on-year change?
Over the past year, CYTK TTM cash from investing has changed by +$851.93M (+135.81%)